We are live on
!
Find out more
ADMA Biologics
ADMA
ADMA
94 hedge funds and large institutions have $88.7M invested in ADMA Biologics in 2020 Q4 according to their latest regulatory filings, with 19 funds opening new positions, 36 increasing their positions, 22 reducing their positions, and 19 closing their positions.
New
Increased
Maintained
Reduced
Closed
64% more repeat investments, than reductions
Existing positions increased: 36 | Existing positions reduced: 22
0% more first-time investments, than exits
New positions opened: 19 | Existing positions closed: 19
1% less funds holding
Funds holding: 95 → 94 (-1)
5.83% less ownership
Funds ownership: 53.54% → 47.71% (-5.8%)
20% less capital invested
Capital invested by funds: $110M → $88.7M (-$21.6M)
42% less call options, than puts
Call options by funds: $1.15M | Put options by funds: $1.97M
Holders
94
Holders Change
-1
Holders Change %
-1.05%
% of All Funds
1.66%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
19
Increased
36
Reduced
22
Closed
19
Calls
$1.15M
Puts
$1.97M
Net Calls
-$820K
Net Calls Change
-$368K
Top Buyers
Top Sellers
| 1 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
-$2.58M |
| 2 |
MFAM
Motley Fool Asset Management
Alexandria,
Virginia
|
-$1.6M |
| 3 |
Alyeska Investment Group
Chicago,
Illinois
|
-$1.06M |
| 4 |
Goldman Sachs
New York
|
-$688K |
| 5 |
IC
Ikarian Capital
Dallas,
Texas
|
-$478K |
